{"id":69022,"date":"2026-03-13T12:06:16","date_gmt":"2026-03-13T12:06:16","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69022"},"modified":"2026-05-21T07:14:11","modified_gmt":"2026-05-21T07:14:11","slug":"igf-1-lr3","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/igf-1-lr3\/","title":{"rendered":"IGF-1 LR3"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Rychl\u00e1 odpov\u011b\u010f \u2014 Co je IGF-1 LR3?<\/h3>\n<p style=\"margin: 0;\"><strong>IGF-1 LR3<\/strong> je v\u00fdzkumn\u00fd peptid dod\u00e1van\u00fd jako lyofilizovan\u00fd pr\u00e1\u0161ek k rekonstituci. Prod\u00e1v\u00e1 se v\u00fdhradn\u011b pro laboratorn\u00ed a v\u00fdzkumn\u00e9 \u00fa\u010dely a <strong>nen\u00ed schv\u00e1len pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed<\/strong> schv\u00e1leno FDA, EMA, MHRA nebo jin\u00fdmi v\u00fdznamn\u00fdmi regul\u00e1tory l\u00e9\u010div. Informace na t\u00e9to str\u00e1nce popisuj\u00ed publikovan\u00e9 preklinick\u00e9 a ran\u00e9 klinick\u00e9 studie; nejedn\u00e1 se o l\u00e9ka\u0159skou radu ani doporu\u010den\u00ed d\u00e1vkov\u00e1n\u00ed. Pro \u00fapln\u00fd p\u0159ehled d\u016fkaz\u016f si p\u0159e\u010dt\u011bte n\u00e1\u0161 n\u00e1vod k v\u00fdzkumu.<\/p>\n<\/div>\n<h2 data-section-id=\"1v2vk1x\">Peptid IGF-1 LR3<\/h2>\n<p><span style=\"font-size: 120%;\">IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) je modifikovan\u00fd analog inzul\u00ednu podobn\u00e9ho r\u016fstov\u00e9ho faktoru-1 ur\u010den\u00fd pro v\u00fdzkum bun\u011b\u010dn\u00e9 r\u016fstov\u00e9 signalizace, anabolick\u00fdch drah a metabolick\u00e9 regulace. Tato prodlou\u017een\u00e1 varianta obsahuje struktur\u00e1ln\u00ed modifikace, kter\u00e9 zvy\u0161uj\u00ed jej\u00ed stabilitu a prodlu\u017euj\u00ed biologickou aktivitu ve srovn\u00e1n\u00ed se standardn\u00edm IGF-1, co\u017e umo\u017e\u0148uje v\u00fdzkumn\u00edk\u016fm studovat dlouhodobou aktivaci receptor\u016f IGF-1 v laboratorn\u00edch modelech. IGF-1 LR3 interaguje s receptory IGF-1 zapojen\u00fdmi do bun\u011b\u010dn\u00e9 proliferace, synt\u00e9zy b\u00edlkovin a vyu\u017eit\u00ed \u017eivin. D\u00edky prodlou\u017een\u00e9mu polo\u010dasu a sn\u00ed\u017een\u00e9 vazb\u011b na IGF-vazebn\u00e9 b\u00edlkoviny poskytuje u\u017eite\u010dn\u00fd r\u00e1mec pro zkoum\u00e1n\u00ed mechanism\u016f souvisej\u00edc\u00edch s r\u016fstem tk\u00e1n\u00ed, metabolickou \u00fa\u010dinnost\u00ed a bun\u011b\u010dn\u00fdmi opravn\u00fdmi procesy. V\u00fdzkumn\u00e9 studie nazna\u010duj\u00ed, \u017ee IGF-1 LR3 m\u016f\u017ee podporovat dr\u00e1hy spojen\u00e9 s r\u016fstem svalov\u00fdch bun\u011bk, zv\u00fd\u0161enou synt\u00e9zou b\u00edlkovin, lep\u0161\u00ed regenerac\u00ed po fyzick\u00e9 z\u00e1t\u011b\u017ei a regulac\u00ed metabolismu gluk\u00f3zy. Jeho aktivita je tak\u00e9 cenn\u00e1 pro zkoum\u00e1n\u00ed regenera\u010dn\u00ed signalizace, bun\u011b\u010dn\u00e9 diferenciace a anabolick\u00fdch odpov\u011bd\u00ed v kontrolovan\u00fdch experiment\u00e1ln\u00edch podm\u00ednk\u00e1ch.<\/span><\/p>\n<hr \/>\n<h2 data-section-id=\"1bovg99\"><strong>P\u0159ehled produktu<\/strong><\/h2>\n<p>IGF-1 LR3 je syntetick\u00fd v\u00fdzkumn\u00fd peptid klasifikovan\u00fd jako modifikovan\u00fd analog inzul\u00ednu podobn\u00e9ho r\u016fstov\u00e9ho faktoru, kter\u00fd byl upraven pro prodlou\u017een\u00ed biologick\u00e9 stability a doby interakce s receptory v laboratorn\u00edch modelech. S molekul\u00e1rn\u00edm vzorcem C400H625N111O115S9 a mol\u00e1rn\u00ed hmotnost\u00ed 9117,60 g\/mol je peptid IGF-1 LR3 \u0161iroce studov\u00e1n ve v\u00fdzkumn\u00fdch prost\u0159ed\u00edch zam\u011b\u0159en\u00fdch na bun\u011b\u010dn\u00e9 r\u016fstov\u00e9 dr\u00e1hy a metabolickou signalizaci. Ka\u017ed\u00e1 lahvi\u010dka obsahuje 0,1 mg nebo 1 mg lyofilizovan\u00e9ho IGF-1 LR3 dod\u00e1van\u00e9ho ve vysoce \u010dist\u00e9 lyofilizovan\u00e9 form\u011b ur\u010den\u00e9 pro laboratorn\u00ed v\u00fdzkum. Peptid je cen\u011bn pro sv\u00e9 struktur\u00e1ln\u00ed modifikace, kter\u00e9 sni\u017euj\u00ed vazbu na IGF-vazebn\u00e9 b\u00edlkoviny a prodlu\u017euj\u00ed aktivitu receptor\u016f v kontrolovan\u00fdch v\u00fdzkumn\u00fdch podm\u00ednk\u00e1ch. P\u0159\u00edklad alternativn\u00edho textu obr\u00e1zku: \u201clyofilizovan\u00e1 lahvi\u010dka s peptidem IGF-1 LR3 pro laboratorn\u00ed v\u00fdzkumn\u00e9 \u00fa\u010dely\u201d. IGF-1 LR3 ur\u010den\u00fd pro v\u00fdzkum si zachov\u00e1v\u00e1 stabilitu p\u0159i spr\u00e1vn\u00fdch skladovac\u00edch podm\u00ednk\u00e1ch s trvanlivost\u00ed p\u0159ibli\u017en\u011b 36 m\u011bs\u00edc\u016f a je ur\u010den v\u00fdhradn\u011b pro v\u00fdzkum a laboratorn\u00ed pou\u017eit\u00ed.<\/p>\n<hr \/>\n<h2 data-section-id=\"engqt1\"><strong>V\u00fdzkumn\u00e9 aplikace<\/strong><\/h2>\n<p>Peptid IGF-1 LR3 se b\u011b\u017en\u011b pou\u017e\u00edv\u00e1 p\u0159i laboratorn\u00edm v\u00fdzkumu bun\u011b\u010dn\u00e9 r\u016fstov\u00e9 signalizace a aktivity anabolick\u00fdch drah. In vitro studie \u010dasto zkoumaj\u00ed aktivaci receptor\u016f IGF-1 a n\u00e1sledn\u00e9 intracelul\u00e1rn\u00ed signaliza\u010dn\u00ed mechanismy spojen\u00e9 se synt\u00e9zou b\u00edlkovin a vyu\u017eit\u00edm \u017eivin. P\u0159edklinick\u00e9 modely pou\u017e\u00edvaj\u00ed IGF-1 LR3 pro v\u00fdzkum k anal\u00fdze vzorc\u016f bun\u011b\u010dn\u00e9 proliferace a reakc\u00ed metabolick\u00e9 regulace. V\u00fdzkumn\u00edci tak\u00e9 zkoumaj\u00ed tk\u00e1\u0148ov\u00e9 kultury, kde lze m\u011b\u0159it signalizaci r\u016fstov\u00fdch faktor\u016f v kontrolovan\u00fdch experiment\u00e1ln\u00edch podm\u00ednk\u00e1ch. IGF-1 LR3 podporuje v\u00fdzkum bun\u011b\u010dn\u00e9 diferenciace, metabolick\u00fdch signaliza\u010dn\u00edch kask\u00e1d a drah anabolick\u00e9 odpov\u011bdi. Tyto aplikace poskytuj\u00ed cenn\u00fd vhled do mechanism\u016f spojen\u00fdch s r\u016fstov\u00fdmi signaliza\u010dn\u00edmi s\u00edt\u011bmi ve v\u00fdzkumn\u00fdch prost\u0159ed\u00edch.<\/p>\n<hr \/>\n<h2 data-section-id=\"g6iwef\"><strong>Rekonstituce a manipulace<\/strong><\/h2>\n<p>Lyofilizovan\u00fd IGF-1 LR3 by m\u011bl b\u00fdt rekonstituov\u00e1n pomoc\u00ed bakteriostatick\u00e9 vody v steriln\u00edm laboratorn\u00edm prost\u0159ed\u00ed. V\u00fdzkumn\u00edci by m\u011bli pou\u017e\u00edt p\u0159\u00edsnou aseptickou techniku p\u0159i zav\u00e1d\u011bn\u00ed rozpou\u0161t\u011bdla do lahvi\u010dky, aby zachovali integritu peptidu a p\u0159esnost experimentu. Roztok vst\u0159ikujte pomalu pod\u00e9l vnit\u0159n\u00ed st\u011bny lahvi\u010dky, aby nedo\u0161lo k destabilizaci peptidu. Vyvarujte se prot\u0159ep\u00e1v\u00e1n\u00ed lahvi\u010dky; m\u00edsto toho jemn\u011b krou\u017eiv\u00fdmi pohyby rozm\u00edchejte, dokud se lyofilizovan\u00fd pr\u00e1\u0161ek IGF-1 LR3 \u00fapln\u011b nerozpust\u00ed. Po rekonstituci skladujte roztok p\u0159i teplot\u011b 2\u20138\u00b0C a udr\u017eujte ho v kontrolovan\u00e9m laboratorn\u00edm prost\u0159ed\u00ed. Spr\u00e1vn\u00e9 postupy manipulace pom\u00e1haj\u00ed zachovat stabilitu peptidu IGF-1 LR3 pro konzistentn\u00ed experiment\u00e1ln\u00ed v\u00fdsledky.<\/p>\n<hr \/>\n<h2 data-section-id=\"evp82x\"><strong>Mechanismus \u00fa\u010dinku<\/strong><\/h2>\n<p>Peptid IGF-1 LR3 prim\u00e1rn\u011b interaguje s receptory inzul\u00ednu podobn\u00e9ho r\u016fstov\u00e9ho faktoru zapojen\u00fdmi do bun\u011b\u010dn\u00e9ho r\u016fstu a metabolick\u00e9 signalizace. Ve v\u00fdzkumn\u00fdch prost\u0159ed\u00edch tato interakce stimuluje intracelul\u00e1rn\u00ed dr\u00e1hy souvisej\u00edc\u00ed se synt\u00e9zou b\u00edlkovin, p\u0159\u00edjmem \u017eivin a markery bun\u011b\u010dn\u00e9 proliferace. Struktur\u00e1ln\u00ed modifikace IGF-1 LR3 sni\u017euje afinitu k IGF-vazebn\u00fdm b\u00edlkovin\u00e1m, co\u017e umo\u017e\u0148uje dlouhodobou aktivaci receptor\u016f v laboratorn\u00edch modelech. In vitro studie nazna\u010duj\u00ed, \u017ee tato prodlou\u017een\u00e1 signalizace m\u016f\u017ee ovlivnit dr\u00e1hy spojen\u00e9 s anabolick\u00fdmi bun\u011b\u010dn\u00fdmi odpov\u011b\u010fmi. V\u00fdzkumn\u00edci pou\u017e\u00edvaj\u00ed IGF-1 LR3 pro v\u00fdzkum k prozkoum\u00e1n\u00ed dynamiky aktivace receptor\u016f a n\u00e1sledn\u00fdch molekul\u00e1rn\u00edch kask\u00e1d. Tyto mechanismy poskytuj\u00ed vhled do regula\u010dn\u00edch proces\u016f spojen\u00fdch s bun\u011b\u010dn\u00fdm r\u016fstem a metabolickou adaptac\u00ed.<\/p>\n<hr \/>\n<h2 data-section-id=\"1dcajhc\"><strong>Pokyny pro v\u00fdzkumn\u00e9 d\u00e1vkov\u00e1n\u00ed<\/strong><\/h2>\n<p>Pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely \u2013 nikoli pro lidsk\u00e9 pou\u017eit\u00ed. Hl\u00e1\u0161en\u00e9 d\u00e1vkovac\u00ed rozsahy ve v\u00fdzkumn\u00e9 literatu\u0159e se li\u0161\u00ed v z\u00e1vislosti na modelov\u00e9m syst\u00e9mu a designu testu. In vitro v\u00fdzkumy \u010dasto pou\u017e\u00edvaj\u00ed koncentrace peptidu IGF-1 LR3 m\u011b\u0159en\u00e9 v rozmez\u00ed nanomol\u00e1rn\u00edch a\u017e mikromol\u00e1rn\u00edch hodnot v z\u00e1vislosti na citlivosti bun\u011b\u010dn\u00e9 linie. P\u0159edklinick\u00e9 experiment\u00e1ln\u00ed modely mohou upravovat koncentra\u010dn\u00ed parametry k vyhodnocen\u00ed reakc\u00ed receptorov\u00e9 signalizace a marker\u016f metabolick\u00e9 aktivity. V\u00fdzkumn\u00edci by m\u011bli ur\u010dit optim\u00e1ln\u00ed koncentra\u010dn\u00ed rozsahy prost\u0159ednictv\u00edm p\u0159edb\u011b\u017en\u00e9ho ov\u011b\u0159en\u00ed testu. Lyofilizovan\u00fd IGF-1 LR3 by m\u011bl b\u00fdt p\u0159ipraven a m\u011b\u0159en pe\u010dliv\u011b, aby byla zachov\u00e1na konzistence experimentu.<\/p>\n<hr \/>\n<h2 data-section-id=\"1pbh8fc\"><strong>Potenci\u00e1ln\u00ed v\u00fdhody v\u00fdzkumu<\/strong><\/h2>\n<ul>\n<li data-section-id=\"1pm95a8\">Bun\u011b\u010dn\u00e9 markery odpov\u011bdi souvisej\u00edc\u00ed se signalizac\u00ed r\u016fstov\u00e9ho faktoru<\/li>\n<li data-section-id=\"1r9cuo2\">Pozorov\u00e1n\u00ed v tk\u00e1\u0148ov\u00fdch kultur\u00e1ch aktivace anabolick\u00fdch drah<\/li>\n<li data-section-id=\"1fytcje\">Stabilita signaliza\u010dn\u00ed aktivity v simulovan\u00fdch metabolick\u00fdch prost\u0159ed\u00edch<\/li>\n<li data-section-id=\"1k1mv77\">Potenci\u00e1l interakce receptor\u016f s signaliza\u010dn\u00edmi drahami IGF-1<\/li>\n<li data-section-id=\"1c1eyxc\">Markery signalizace angiogenn\u00edch a prolifera\u010dn\u00edch drah<\/li>\n<\/ul>\n<hr \/>\n<h2 data-section-id=\"1tir0k8\"><strong>Experiment\u00e1ln\u00ed pozorov\u00e1n\u00ed<\/strong><\/h2>\n<p>Laboratorn\u00ed v\u00fdzkumy zahrnuj\u00edc\u00ed peptid IGF-1 LR3 \u010dasto pozoruj\u00ed zv\u00fd\u0161enou signaliza\u010dn\u00ed aktivitu v drah\u00e1ch receptor\u016f IGF-1 v kontrolovan\u00fdch experiment\u00e1ln\u00edch podm\u00ednk\u00e1ch. In vitro modely bun\u011b\u010dn\u00fdch kultur demonstruj\u00ed m\u011b\u0159iteln\u00e9 zm\u011bny v markerech bun\u011b\u010dn\u00e9 proliferace a ukazatel\u00edch synt\u00e9zy protein\u016f. V\u00fdzkumn\u00edci studuj\u00edc\u00ed metabolickou signalizaci \u010dasto dokumentuj\u00ed zm\u011bny v drah\u00e1ch p\u0159\u00edjmu \u017eivin, kdy\u017e je IGF-1 LR3 zaveden do experiment\u00e1ln\u00edch syst\u00e9m\u016f. Preklinick\u00e9 modely tak\u00e9 zkoumaly IGF-1 LR3 ve vztahu k signalizaci diferenciace a vzorc\u016fm bun\u011b\u010dn\u00e9ho v\u00fdvoje. Tato pozorov\u00e1n\u00ed p\u0159isp\u00edvaj\u00ed k pochopen\u00ed, jak trval\u00e1 aktivace receptor\u016f ovliv\u0148uje slo\u017eit\u00e9 bun\u011b\u010dn\u00e9 s\u00edt\u011b. IGF-1 LR3 pro v\u00fdzkum tedy poskytuje reprodukovateln\u00fd r\u00e1mec pro studium anabolick\u00fdch signaliza\u010dn\u00edch drah v experiment\u00e1ln\u00edch v\u00fdzkumn\u00fdch podm\u00ednk\u00e1ch.<\/p>\n<hr \/>\n<h2 data-section-id=\"1pt12ft\"><strong>V\u00fdzkumn\u00e9 aspekty<\/strong><\/h2>\n<p>V\u00fdzkumn\u00edci pracuj\u00edc\u00ed s IGF-1 LR3 by m\u011bli zajistit p\u0159\u00edsn\u00e9 dodr\u017eov\u00e1n\u00ed laboratorn\u00edch protokol\u016f, aby udr\u017eeli stabilitu peptidu a platnost experiment\u016f. Environment\u00e1ln\u00ed podm\u00ednky, jako je teplota, kompatibilita rozpou\u0161t\u011bdel a citlivost test\u016f, mohou ovlivnit chov\u00e1n\u00ed peptidu ve studi\u00edch in vitro. P\u0159ed zah\u00e1jen\u00edm rozs\u00e1hlej\u0161\u00edho laboratorn\u00edho v\u00fdzkumu se doporu\u010duje pe\u010dliv\u00e1 kalibrace koncentrac\u00ed. Peptid IGF-1 LR3 m\u016f\u017ee interagovat s dal\u0161\u00edmi r\u016fstov\u00fdmi faktory nebo signaliza\u010dn\u00edmi molekulami v r\u00e1mci slo\u017eit\u00fdch experiment\u00e1ln\u00edch syst\u00e9m\u016f. Dokumentace postup\u016f manipulace a experiment\u00e1ln\u00edch parametr\u016f je nezbytn\u00e1 pro reprodukovatelnost. Ve\u0161ker\u00e1 pr\u00e1ce s IGF-1 LR3 mus\u00ed z\u016fstat v r\u00e1mci schv\u00e1len\u00fdch v\u00fdzkumn\u00fdch a laboratorn\u00edch sm\u011brnic.<\/p>\n<hr \/>\n<h2 data-section-id=\"y0g1yb\"><strong>Bezpe\u010dnostn\u00ed upozorn\u011bn\u00ed<\/strong><\/h2>\n<p>Peptid IGF-1 LR3 by m\u011bl b\u00fdt manipulov\u00e1n za pou\u017eit\u00ed standardn\u00edch laboratorn\u00edch bezpe\u010dnostn\u00edch praktik, v\u010detn\u011b ochrann\u00fdch pom\u016fcek a vhodn\u00fdch postup\u016f pro zaji\u0161t\u011bn\u00ed. V\u00fdzkumn\u00edci mus\u00ed zajistit, aby byla slou\u010denina skladov\u00e1na, manipulov\u00e1na a likvidov\u00e1na podle institucion\u00e1ln\u00edch laboratorn\u00edch bezpe\u010dnostn\u00edch sm\u011brnic. P\u0159\u00edm\u00e9 vystaven\u00ed by m\u011blo b\u00fdt minimalizov\u00e1no a p\u0159i p\u0159\u00edprav\u011b experiment\u00e1ln\u00edch roztok\u016f by m\u011bly b\u00fdt pou\u017eity laboratorn\u00ed n\u00e1stroje. Tento peptid je ur\u010den v\u00fdhradn\u011b pro v\u011bdeck\u00fd v\u00fdzkum a nesm\u00ed b\u00fdt pou\u017e\u00edv\u00e1n mimo kontrolovan\u00e1 v\u00fdzkumn\u00e1 prost\u0159ed\u00ed. IGF-1 LR3 nen\u00ed schv\u00e1len pro lidsk\u00e9 nebo veterin\u00e1rn\u00ed pou\u017eit\u00ed a m\u011bl by b\u00fdt pou\u017e\u00edv\u00e1n pouze v profesion\u00e1ln\u00edch v\u00fdzkumn\u00fdch za\u0159\u00edzen\u00edch.<\/p>\n<p>Disclaimer: Tento produkt je ur\u010den v\u00fdhradn\u011b pro \u00fa\u010dely laboratorn\u00edho v\u00fdzkumu a nen\u00ed vhodn\u00fd pro lidsk\u00e9 nebo veterin\u00e1rn\u00ed pou\u017eit\u00ed. Poskytnut\u00e9 informace slou\u017e\u00ed pouze pro vzd\u011bl\u00e1vac\u00ed a v\u011bdeck\u00e9 \u00fa\u010dely a nem\u011bly by b\u00fdt interpretov\u00e1ny jako l\u00e9ka\u0159sk\u00e1 rada nebo doporu\u010den\u00ed jak\u00e9hokoli zp\u016fsobu pod\u00e1n\u00ed. V\u00fdzkumn\u00edci by m\u011bli p\u0159i manipulaci s t\u00edmto materi\u00e1lem dodr\u017eovat v\u0161echny platn\u00e9 p\u0159edpisy a institucion\u00e1ln\u00ed sm\u011brnice.<\/p>\n<hr \/>\n<h2 data-section-id=\"1xqr4ds\"><strong>Informace o skladov\u00e1n\u00ed<\/strong><\/h2>\n<p>Lyofilizovan\u00fd IGF-1 LR3 skladujte p\u0159i \u221220\u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed, aby byla zachov\u00e1na stabilita peptidu a struktur\u00e1ln\u00ed integrita. Pro kr\u00e1tkodob\u00e9 laboratorn\u00ed pou\u017eit\u00ed m\u016f\u017ee b\u00fdt peptid skladov\u00e1n p\u0159i 2\u20138\u00b0C v kontrolovan\u00fdch chladic\u00edch podm\u00ednk\u00e1ch. Chra\u0148te IGF-1 LR3 p\u0159ed p\u0159\u00edm\u00fdm sv\u011btlem, aby nedo\u0161lo k degradaci struktury peptidu. Vyhn\u011bte se opakovan\u00fdm cykl\u016fm zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed, proto\u017ee ty mohou sn\u00ed\u017eit stabilitu peptidu a ovlivnit reprodukovatelnost experiment\u016f. P\u0159i spr\u00e1vn\u00e9m skladov\u00e1n\u00ed si IGF-1 LR3 zachov\u00e1v\u00e1 trvanlivost p\u0159ibli\u017en\u011b 36 m\u011bs\u00edc\u016f. Spr\u00e1vn\u00e9 skladov\u00e1n\u00ed zaji\u0161\u0165uje spolehliv\u00fd laboratorn\u00ed v\u00fdkon lyofilizovan\u00e9ho IGF-1 LR3 pro v\u00fdzkum.<\/p>\n<h2><strong>\u010cistota a kvalita<\/strong><\/h2>\n<p>V\u0161echny lahvi\u010dky IGF-1 LR3 skladovan\u00e9 spole\u010dnost\u00ed MedsBase jsou dod\u00e1v\u00e1ny v lyofilizovan\u00e9 form\u011b s \u010distotou 99 %+ HPLC. Certifik\u00e1t anal\u00fdzy (COA) je k dispozici na vy\u017e\u00e1d\u00e1n\u00ed \u2013 po objedn\u00e1n\u00ed kontaktujte n\u00e1\u0161 t\u00fdm podpory a my v\u00e1m za\u0161leme d\u00e1vkov\u011b specifick\u00fd COA pro obdr\u017een\u00e9 lahvi\u010dky.<\/p>\n<h2>\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>Jak\u00fd je regula\u010dn\u00ed status IGF-1 LR3?<\/h3>\n<p>IGF-1 LR3 je <strong>nen\u00ed schv\u00e1len pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed<\/strong> ve Spojen\u00fdch st\u00e1tech, Evropsk\u00e9 unii, Spojen\u00e9m kr\u00e1lovstv\u00ed, Kanad\u011b nebo Austr\u00e1lii. Prod\u00e1v\u00e1 se pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely. N\u011bkter\u00e9 peptidy t\u00e9to t\u0159\u00eddy byly pou\u017eity v ran\u00fdch f\u00e1z\u00edch klinick\u00fdch studi\u00ed, ale \u017e\u00e1dn\u00fd v\u00fdznamn\u00fd regul\u00e1tor nevydal povolen\u00ed k uveden\u00ed na trh pro indikace diskutovan\u00e9 v popul\u00e1rn\u00ed literatu\u0159e.<\/p>\n<h3>Jak se IGF-1 LR3 rekonstituuje?<\/h3>\n<p>Lyofilizovan\u00e9 peptidy se obvykle rekonstituuj\u00ed bakteriostatickou vodou nebo steriln\u00ed vodou pro injekci (BWFI \/ SWFI) v koncentraci vhodn\u00e9 pro pl\u00e1novanou d\u00e1vku. P\u0159idejte \u0159edidlo pomalu po vnit\u0159n\u00ed st\u011bn\u011b lahvi\u010dky \u2013 nest\u0159\u00edkejte proud p\u0159\u00edmo do pr\u00e1\u0161kov\u00e9 hmoty ani lahvi\u010dku prudce net\u0159epejte, proto\u017ee oboj\u00ed m\u016f\u017ee denaturovat peptid. Jemn\u011b krou\u017eiv\u00fdmi pohyby rozm\u00edchejte, dokud se \u00fapln\u011b nerozpust\u00ed. Rekonstituovan\u00e9 peptidy se obvykle skladuj\u00ed v chladni\u010dce p\u0159i teplot\u011b 2\u20138 \u00b0C.<\/p>\n<h3>Jak by m\u011bl b\u00fdt IGF-1 LR3 skladov\u00e1n?<\/h3>\n<p>Lyofilizovan\u00e9 lahvi\u010dky jsou stabiln\u00ed po dlouhou dobu p\u0159i skladov\u00e1n\u00ed p\u0159i \u221220 \u00b0C nebo v chladni\u010dce p\u0159i 2\u20138 \u00b0C, mimo p\u0159\u00edm\u00e9 sv\u011btlo. Po rekonstituci je v\u011bt\u0161ina peptid\u016f stabiln\u00edch po dobu 14\u201330 dn\u016f v chladni\u010dce, v z\u00e1vislosti na pufru a konkr\u00e9tn\u00edm peptidu. V\u017edy si p\u0159e\u010dt\u011bte certifik\u00e1t anal\u00fdzy dod\u00e1van\u00fd s lahvi\u010dkou, kde najdete doporu\u010den\u00e9 skladov\u00e1n\u00ed a \u00fadaje o stabilit\u011b od dodavatele.<\/p>\n<h3>Co ukazuj\u00ed publikovan\u00e9 v\u00fdzkumy?<\/h3>\n<p>Publikovan\u00e1 literatura o IGF-1 LR3 je shrnuta v na\u0161em propojen\u00e9m v\u00fdzkumn\u00e9m pr\u016fvodci. Odd\u011blujeme preklinick\u00e1 data (u hlodavc\u016f \/ bun\u011b\u010dn\u00fdch kultur), kde jsou konzistentn\u00ed a reprodukovateln\u00e1, od klinick\u00fdch studi\u00ed, kde jsou d\u016fkazy obvykle slab\u0161\u00ed. Rovn\u011b\u017e upozor\u0148ujeme na p\u0159\u00edpady, kdy popul\u00e1rn\u00ed online tvrzen\u00ed p\u0159ekra\u010duj\u00ed publikovan\u00e9 \u00fadaje.<\/p>\n<h3>Je IGF-1 LR3 leg\u00e1ln\u00ed objednat mezin\u00e1rodn\u011b?<\/h3>\n<p>V\u00fdzkumn\u00e9 peptidy zauj\u00edmaj\u00ed nejednozna\u010dn\u00e9 regula\u010dn\u00ed postaven\u00ed. Pravidla pro dovoz se li\u0161\u00ed podle zem\u011b a v n\u011bkolika jurisdikc\u00edch se v posledn\u00edch letech zm\u011bnila. P\u0159ed objedn\u00e1n\u00edm je odpov\u011bdnost\u00ed kupuj\u00edc\u00edho ov\u011b\u0159it legalitu dovozu v c\u00edlov\u00e9 zemi. MedsBase expeduje peptidy po cel\u00e9m sv\u011bt\u011b prost\u0159ednictv\u00edm na\u0161eho specializovan\u00e9ho kur\u00fdra pro peptidy; objedn\u00e1vky, kter\u00e9 poru\u0161uj\u00ed dovozn\u00ed pravidla c\u00edlov\u00e9 zem\u011b, mohou b\u00fdt zadr\u017eeny na celnici.<\/p>\n<h3>Jak\u00fd je polo\u010das IGF-1 LR3?<\/h3>\n<p>IGF-1 LR3 m\u00e1 podle preklinick\u00e9ho v\u00fdzkumu odhadovan\u00fd polo\u010das 20\u201330 hodin \u2014 v\u00fdrazn\u011b del\u0161\u00ed ne\u017e p\u0159irozen\u00fd IGF-1 (p\u0159ibli\u017en\u011b 6\u20138 hodin). Modifikace LR3 sni\u017euje afinitu k IGF-v\u00e1zaj\u00edc\u00edm protein\u016fm (IGFBP), \u010d\u00edm\u017e zvy\u0161uje volnou (biologicky dostupnou) frakci IGF-1 v krevn\u00edm ob\u011bhu a prodlu\u017euje dobu \u00fa\u010dinku.<\/p>\n<h3>Jak se IGF-1 LR3 li\u0161\u00ed od p\u0159irozen\u00e9ho IGF-1?<\/h3>\n<p>IGF-1 LR3 je 83-aminokyselinov\u00fd analog p\u0159irozen\u011b se vyskytuj\u00edc\u00edho 70-aminokyselinov\u00e9ho IGF-1. Modifikace LR3 v\u00fdznamn\u011b sni\u017euje vazbu na \u0161est zn\u00e1m\u00fdch IGF-v\u00e1zaj\u00edc\u00edch protein\u016f (IGFBPs), kter\u00e9 norm\u00e1ln\u011b v\u00e1\u017eou ~98 % endogenn\u00edho IGF-1. To vede k v\u00fdrazn\u011b vy\u0161\u0161\u00ed frakci voln\u00e9ho peptidu a prodlou\u017een\u00e9mu polo\u010dasu, co\u017e \u010din\u00ed IGF-1 LR3 preferovanou slou\u010deninou ve v\u00fdzkumu vy\u017eaduj\u00edc\u00edm prodlou\u017eenou aktivaci receptoru IGF-1.<\/p>\n<h3>Mohu objednat IGF-1 LR3 spolu s dal\u0161\u00edmi peptidy?<\/h3>\n<p>Ano. Objedn\u00e1vky peptid\u016f jsou sdru\u017eov\u00e1ny a odes\u00edl\u00e1ny spole\u010dn\u011b prost\u0159ednictv\u00edm na\u0161\u00ed kur\u00fdrn\u00ed slu\u017eby v\u00fdhradn\u011b pro peptidy. Lyofilizovan\u00e9 lahvi\u010dky jsou teplotn\u011b stabiln\u00ed po dobu standardn\u00ed mezin\u00e1rodn\u00ed p\u0159epravy. Prohl\u00e9dn\u011bte si na\u0161i kategorii peptid\u016f pro kompletn\u00ed nab\u00eddku a pr\u016fvodce \u201cNejlep\u0161\u00ed peptidy pro regeneraci\u201d pro informace o kombinov\u00e1n\u00ed z publikovan\u00e9 literatury.<\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">Protokoly s IGF-1 LR3 \u010dasto zahrnuj\u00ed BPC-157 a TB-500 pro podporu kloub\u016f a \u0161lach b\u011bhem anabolick\u00e9 f\u00e1ze \u0159\u00edzen\u00e9 IGF-1; na\u0161e <a href=\"\/cs\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + bakteriostatick\u00e1 voda)<\/a> balen\u00ed obsahuj\u00ed jak lyofilizovan\u00e9 vialy, tak rekonstitu\u010dn\u00ed vodu za cenu dopravy peptid\u016f $0.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Dal\u0161\u00ed peptidy pro v\u00fdzkum regenerace a v\u00fdkonnosti<\/h2>\n<ul>\n<li><a href=\"\/cs\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 v\u00fdzkum regenerace \u0161lach, vaz\u016f a st\u0159ev<\/li>\n<li><a href=\"\/cs\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Fragment Thymosin Beta-4 \u2014 v\u00fdzkum regenerace m\u011bkk\u00fdch tk\u00e1n\u00ed a c\u00e9v<\/li>\n<li><a href=\"\/cs\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Selektivn\u00ed agonista ghrelinu \u2014 \u010dist\u00fd pulz r\u016fstov\u00e9ho hormonu bez kortizolu\/prolaktinu<\/li>\n<li><a href=\"\/cs\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 Analog GHRH s prodlou\u017een\u00fdm polo\u010dasem<\/li>\n<li><a href=\"\/cs\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 M\u011b\u010fn\u00fd peptid \u2014 v\u00fdzkum regenerace k\u016f\u017ee a pojivov\u00e9 tk\u00e1n\u011b<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Dal\u0161\u00ed \u010dten\u00ed<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Seznamte se s v\u00fdzkumem tohoto peptidu<\/strong><\/p>\n<p style=\"margin: 0;\">P\u0159e\u010dt\u011bte si n\u00e1\u0161 kompletn\u00ed pr\u016fvodce zalo\u017een\u00fd na d\u016fkazech: <a href=\"https:\/\/medsbase.com\/cs\/igf-1-lr3-peptide-guide\/\"><strong>IGF-1 LR3 \u2014 v\u011bdeck\u00e9 informace, d\u00e1vkov\u00e1n\u00ed a bezpe\u010dnost<\/strong><\/a>. Pokr\u00fdv\u00e1 mechanismus \u00fa\u010dinku, publikovan\u00e1 v\u00fdzkumn\u00e1 data, obvykl\u00e9 rozsahy v\u00fdzkumn\u00e9ho d\u00e1vkov\u00e1n\u00ed, protokoly pro rekonstituci, mo\u017enosti kombinace a pozn\u00e1mky k bezpe\u010dnosti\/kontraindikac\u00edm.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdzkumn\u00e9 lyofilizovan\u00e9 peptidy \u00b7 HPLC \u010distota \u226599% (COA na vy\u017e\u00e1d\u00e1n\u00ed) \u00b7 Diskr\u00e9tn\u00ed teplotn\u011b stabiln\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 p\u0159eprava peptid\u016f \u00b7 1,400+ ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifikace<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS \u010d\u00edslo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">946870-92-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item2<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>400<\/sub>H<sub>625<\/sub>N<sub>111<\/sub>O<sub>120<\/sub>S<sub>9<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~9117.4 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Long R<sup>3<\/sup> IGF-1 (83 aminokyselin; N-termin\u00e1ln\u00ed MFPAMPLSSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item11<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd pr\u00e1\u0161ek (nebo v dodan\u00e9 form\u011b)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item13<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC ov\u011b\u0159eno, COA na vy\u017e\u00e1d\u00e1n\u00ed)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Skladov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd: 2\u20138 \u00b0C (lednice) pro pracovn\u00ed z\u00e1sobu; \u221220 \u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch vialek. Rekonstituovan\u00fd: 2\u20138 \u00b0C, pou\u017e\u00edt do ~30 dn\u016f. Vyvarujte se prudk\u00e9ho prot\u0159ep\u00e1v\u00e1n\u00ed; velk\u00e9 peptidy se t\u0159ep\u00e1n\u00edm denaturuj\u00ed. Nefreeze\u2013thaw rekonstituovan\u00fd roztok.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Rozpustnost<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatick\u00e1 voda (doporu\u010deno) nebo steriln\u00ed voda pro krat\u0161\u00ed dobu pou\u017eit\u00ed<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pouze pro v\u00fdzkum<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pouze pro laboratorn\u00ed v\u00fdzkum. Nen\u00ed ur\u010deno pro diagnostick\u00e9 nebo terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed nebo zv\u00ed\u0159at.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Podporuje bun\u011b\u010dn\u00fd r\u016fst<br \/>\n\u2705 Zlep\u0161uje synt\u00e9zu b\u00edlkovin<br \/>\n\u2705 Zlep\u0161uje metabolick\u00e9 signalizace<br \/>\n\u2705 Zlep\u0161uje regeneraci tk\u00e1n\u00ed<br \/>\n\u2705 Posiluje bun\u011b\u010dnou opravu<\/p>\n<p><strong>IGF-1 LR3<\/strong> obsahuje syntetickou peptidovou slou\u010deninu.<\/p>","protected":false},"featured_media":70960,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5474],"class_list":{"0":"post-69022","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-igf-1-lr3","9":"first","10":"instock","11":"shipping-taxable","12":"purchasable","13":"product-type-variable","14":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/69022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=69022"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/70960"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=69022"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=69022"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=69022"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=69022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}